A recent study from Oregon State University (OSU) found that two compounds rich in live cannabis plants can be used to prevent the virus that causes COVID-19 from entering human cells.
The study, published Monday, January 10 in the peer-reviewed journal Natural Products Journal, tested the potential affinity of several plant extracts, such as wild yam, hops, red clover and licorice, for Covid spike proteins .
According to the findings, cannabidiolic acid, CBDA and cannabidiolic acid (CBGA) can bind to the spike protein of the SARS-Cov-2 virus. This spike is why coronaviruses are used to hijack human cells. By binding to this spike protein, the same spike protein used in Covid-19 vaccines and antibody therapeutics, these compounds block a key step in the virus’s infection of humans.
Before you get too excited about starting or slapping, however, this research also suggests that these two compounds may not be consumed by any conventional method and have this benefit.
These compounds must be harvested individually and then used to make specific medicines.
”These cannabinoid acids are abundant in cannabis and many cannabis extracts,” said OSU lead author Richard van Breemen.
These CBDA and CBGA compounds are not regulated substances, like THC, the active ingredient in marijuana, and they have a good safety profile for humans. Studies have shown that these cannabinoids are equally effective against SARS-Cov-2 variants.